DISTINGUISHING FEATURES OF AN INFECTIOUS MOLECULAR CLONE OF THE HIGHLY DIVERGENT AND NONCYTOPATHIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 UC1 STRAIN

被引:27
作者
BARNETT, SW [1 ]
QUIROGA, M [1 ]
WERNER, A [1 ]
DINA, D [1 ]
LEVY, JA [1 ]
机构
[1] CHIRON CORP, EMERYVILLE, CA 94608 USA
关键词
D O I
10.1128/JVI.67.2.1006-1014.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A full-length infectious molecular clone was derived from the noncytopathic human immunodeficiency virus type 2 UC1 strain (HIV-2UC1) that was originally recovered from an individual from the Ivory Coast. Like the parental isolate, the molecularly cloned virus (HIV-2UC1mc or UC1mc) demonstrates a reduced ability to induce syncytium formation, to kill cells, and to down-modulate the cell surface CD4 receptor in infected cells. Phylogenetic analysis of the DNA sequence of UC1mc revealed that it is the first full-length infectious molecular clone in the second HIV-2 subgroup previously identified by partial sequence analysis of the HIV-2D205 and HIV-2GH-2 strains. These highly divergent HIV-2 strains appear to be genetically equidistant from other HIV-2 and simian immunodeficiency virus SIV(mac/sm) strains. UC1mc is unlike any other HIV-2 or SIV(mac/sm) strain in that it lacks a cysteine residue at the proposed signal peptide cleavage site in Env. However, site-directed mutagenesis experiments indicate that this missing cysteine is not alone important in the noncytopathic phenotype of UC1mc. Like other HIV-2 and SIV strains, the UC1mc Env transmembrane protein (gp43) is mutated to a truncated form (gp34) after passage in certain T-cell lines. The UC1 molecular clone should be helpful in determining the genetic sequences associated with HIV-2 cytopathicity.
引用
收藏
页码:1006 / 1014
页数:9
相关论文
共 61 条
[1]   CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS RECOVERED FROM THE BOWEL OF INFECTED INDIVIDUALS [J].
BARNETT, SW ;
BARBOZA, A ;
WILCOX, CM ;
FORSMARK, CE ;
LEVY, JA .
VIROLOGY, 1991, 182 (02) :802-809
[2]  
BARNETT SW, UNPUB
[3]   IDENTIFICATION OF THE FUSION PEPTIDE OF PRIMATE IMMUNODEFICIENCY VIRUSES [J].
BOSCH, ML ;
EARL, PL ;
FARGNOLI, K ;
PICCIAFUOCO, S ;
GIOMBINI, F ;
WONGSTAAL, F ;
FRANCHINI, G .
SCIENCE, 1989, 244 (4905) :694-697
[4]  
BURNY A, 1988, J ACQ IMMUN DEF SYND, V1, P579
[5]   BIOLOGIC HETEROGENEITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 (HIV-2) STRAINS [J].
CASTRO, BA ;
BARNETT, SW ;
EVANS, LA ;
MOREAU, J ;
ODEHOURI, K ;
LEVY, JA .
VIROLOGY, 1990, 178 (02) :527-534
[6]   OPTIMAL CONDITIONS FOR RECOVERY OF THE HUMAN IMMUNODEFICIENCY VIRUS FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
CASTRO, BA ;
WEISS, CD ;
WIVIOTT, LD ;
LEVY, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (11) :2371-2376
[7]   SEQUENCE OF SIMIAN IMMUNODEFICIENCY VIRUS FROM MACAQUE AND ITS RELATIONSHIP TO OTHER HUMAN AND SIMIAN RETROVIRUSES [J].
CHAKRABARTI, L ;
GUYADER, M ;
ALIZON, M ;
DANIEL, MD ;
DESROSIERS, RC ;
TIOLLAIS, P ;
SONIGO, P .
NATURE, 1987, 328 (6130) :543-547
[8]   THE CYTOPLASMIC DOMAIN OF SIMIAN IMMUNODEFICIENCY VIRUS TRANSMEMBRANE PROTEIN MODULATES INFECTIVITY [J].
CHAKRABARTI, L ;
EMERMAN, M ;
TIOLLAIS, P ;
SONIGO, P .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4395-4403
[9]   HOST RANGE, REPLICATIVE, AND CYTOPATHIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE DETERMINED BY VERY FEW AMINO-ACID CHANGES IN TAT AND GP120 [J].
CHENGMAYER, C ;
SHIODA, T ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6931-6941
[10]   VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION [J].
CHENGMAYER, C ;
QUIROGA, M ;
TUNG, JW ;
DINA, D ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4390-4398